Cross-Modality Generation of Amyloid PET from FDG PET for Alzheimer’s Disease Diagnosis

Yu Fu,Le Xue,Yi Liao,Lin Chen,Meng Niu,Hong Zhang,Mei Tian,Cheng Zhuo
DOI: https://doi.org/10.1109/bibm52615.2021.9669287
2021-01-01
Abstract:Positron Emission Tomography (PET) has been widely used in the early diagnosis and treatment monitoring of Alzheimer’s Disease (AD). As two radiotracers of neurodegeneration, [18F]Fluorodeoxyglucose ([18F]FDG) and [18F]Florbetapir ([18F]AV45) PET have been used to measure cerebral glucose metabolism and $\beta$-amyloid $(A\beta)$ deposition, respectively. The combination of different modality PET images, such as FDG PET and AV45 PET, can provide complementary information for clinical diagnosis and evaluation. However, compared to the actual and available FDG PET data, AV45 PET data is always deficient due to the institution-specific tracers. In this paper, we propose a lightweight Generative Adversarial Network (GAN)-based model, which is termed “dual perceptual loss based generative adversarial network (DPGAN) for fast 2. 5D-based cross-modality generation of AV45 PET from FDG PET. This model provides a potential supplementary solution to those clinical situations that only the FDG PET image is acquired, but the AV45 PET is missing. Our experimental results showed that the DPGAN outperformed recent CycleGAN and pGAN, given its stronger ability in capturing the $A \beta$ deposition patterns on the whole-brain scale. All qualitative and quantitative metrics demonstrated the strong similarity between the generated AV45 PET images using DPGAN and the original AV45 PET images.
What problem does this paper attempt to address?